Patient
SITE012-0019
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)
consented 2025-09-08
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-02 (study day 344); relationship: NOT RELATED
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-02-20 (study day 334); relationship: RELATED
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-03 (study day 317); relationship: NOT RELATED
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-11-26 (study day 248); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.